Jih Ru Hwu | Medicine and Health Sciences | Lifetime achievement Award

Published on by Research Hypothesis

Prof. Jih Ru Hwu | Medicine and Health Sciences | Lifetime achievement Award

Distinguished Chair Professor at National Tsing Hua University, Taiwan

Professor Reuben Jih-Ru Hwu is a Distinguished Chair Professor Emeritus with Lifetime Honor at National Tsing Hua University, Taiwan, and a globally recognized chemist whose career spans over four decades of pioneering research and academic excellence. Earning his Ph.D. from Stanford University in 1982, he served as a faculty member at Johns Hopkins University before returning to Asia, where he built an outstanding interdisciplinary research portfolio in drug design, DNA-cleaving agents, nano-biomaterials, organosilicon chemistry, natural product synthesis, and green chemistry. With over 253 publications and 52 patents, his contributions reflect both scientific rigor and practical innovation. Professor Hwu has been honored with numerous prestigious awards, including the TWAS Award, the Chinese American Chemical Society’s Outstanding Achievement Award, and the Taiwan National Chair Professorship. He is a Fellow of esteemed organizations such as TWAS, IUPAC, the Royal Society of Chemistry, and the European Academy of Sciences and Arts. His leadership roles, including presidencies of major chemical societies such as FACS and the Asian Federation for Medicinal Chemistry, further underscore his influential presence in the global scientific community.

Professional Profile 

🎓 Education of Professor Reuben Jih-Ru Hwu

Professor Reuben Jih-Ru Hwu began his academic journey with a strong foundation in chemistry, culminating in a Ph.D. in Chemistry from the prestigious Stanford University in 1982. His doctoral training at Stanford equipped him with cutting-edge expertise in chemical research, setting the stage for his impactful scientific career. Prior to that, he demonstrated exceptional academic promise, which was later recognized through multiple international awards and fellowships. His educational background reflects both academic excellence and a commitment to innovation, shaping him into a global leader in multidisciplinary chemical sciences.

💼 Professional Experience of Professor Reuben Jih-Ru Hwu

Professor Reuben Jih-Ru Hwu has had a distinguished professional career marked by academic leadership, research excellence, and international collaboration. After earning his Ph.D. from Stanford University in 1982, he began his academic tenure as a faculty member at Johns Hopkins University, where he served from 1982 to 1991. He later returned to Taiwan and became a Distinguished Chair Professor at National Tsing Hua University, where he was eventually honored as Professor Emeritus with Lifetime Honor. Throughout his career, Professor Hwu has led groundbreaking research across diverse areas such as medicinal chemistry, nano-biomaterials, green chemistry, and synthetic methodology. He has also held key leadership roles in international scientific organizations, including serving as President of the Chinese American Chemical Society, the Asian Federation for Medicinal Chemistry, and the Federation of Asian Chemical Societies, demonstrating his global impact and commitment to advancing chemical sciences worldwide.

🔬 Research Interests of Professor Reuben Jih-Ru Hwu

Professor Reuben Jih-Ru Hwu’s research interests span a broad and impactful spectrum of chemical sciences, reflecting his passion for innovation and interdisciplinary exploration. His work encompasses drug design and synthesis, the development of DNA-cleaving agents, and the creation of advanced nano-biomaterials for biomedical applications. He has made significant contributions to natural product synthesis, organosilicon chemistry, and the discovery of novel chemical reactions and reagents. In recent years, Professor Hwu has also focused on sustainability and green chemistry, aiming to develop eco-friendly chemical processes. His diverse and forward-looking research not only advances scientific knowledge but also addresses critical global challenges in health, environment, and technology.

🏅 Awards and Honors of Professor Reuben Jih-Ru Hwu

Professor Reuben Jih-Ru Hwu has received numerous prestigious awards and honors that reflect his outstanding contributions to the chemical sciences. Notable recognitions include the 2023 Outstanding Achievement Award from the Chinese American Chemical Society, the Gulf Chemistry Association Trophy (2022), and the CAS Registry Innovator Award (2022). He has also been honored with the Taiwan National Chair Professorship, the TWAS Award (1997), and was named one of the JCI Ten Outstanding Young Persons of the World (1994). Earlier in his career, he received the FACS Distinguished Young Chemist Award (1992–93), the Alfred P. Sloan Research Fellowship (1986–1990), and the Stuart Pharmaceuticals Achievement Award (1986). His accolades span decades and continents, highlighting his influence in both academic and applied chemistry. These awards are a testament to his innovation, leadership, and lifelong dedication to advancing science.

✅Conclusion

Professor Reuben Jih-Ru Hwu is a highly qualified and exceptional candidate for the Best Researcher Award. His prolific academic output, international recognitions, scientific leadership, and broad research contributions place him among the top-tier scientists in the field of chemistry and interdisciplinary sciences. With slight enhancement in showcasing his recent impactful contributions and societal influence, his nomination would not only be justified but compelling on a global scale.

📚 Publications

1. Calcium Impregnated Silica Gel in the Domino Reaction Involving Irreversible Aldol Addition, Dehydration, and Michael Addition

  • Title: Calcium Impregnated Silica Gel in the Domino Reaction Involving Irreversible Aldol Addition, Dehydration, and Michael AdditionAuthors: Jih Ru Hwu, Khagendra Prasad Bohara, Mohit Kapoor, et al. (with collaborators from National Tsing Hua University and affiliated institutes)
  • Journal: Journal of Organic Chemistry
  • Year: 2025 (published ~2 months ago from June 2025)
  • Citations: 0

2. 6‑Chlorocoumarin Conjugates with Nucleobases and Nucleosides as Potent Anti‑Hepatitis C Virus Agents

  • Title: 6‑Chlorocoumarin Conjugates with Nucleobases and Nucleosides as Potent Anti‑Hepatitis C Virus Agents
  • Authors: Shu‑Yu Lin, Wen‑Chieh Huang, Shwu‑Chen Tsay, Johan Neyts, Pieter Leyssen, Chun‑Cheng Lin, Kuo Chu Hwang, Jia‑Cherng Horng, and Jih Ru Hwu
  • Journal: Molecules (Open access)
  • Year: 2025 (Volume 30, Issue 8, Article 1776)
  • Citations: 0

 

 

Jwee Chiek Er | Biology and Life Sciences | Pioneer Researcher Award

Published on by Research Hypothesis

Jwee Chiek Er | Biology and Life Sciences | Pioneer Researcher Award

Researcher, Norwegian Veterinary Institution, Norway

Dr. Jwee Chiek Er is a distinguished veterinary epidemiologist and researcher dedicated to advancing animal health. 🐖📈 Since 2007, he has worked full-time at the Norwegian Veterinary Institute, focusing on epidemiology and bioinformatics. 🇳🇴🔬 He also serves part-time as a church servant at Uranienborg Menighet since 2020. ⛪ Previously, Dr. Er contributed significantly to veterinary inspection in Singapore’s pig and poultry slaughterhouses (1991–2006) and served as a Captain in the Singapore Armed Forces (1989–1991). 🛡️🏥 With a Ph.D. from the University of Life Sciences, Norway, an MPVM from UC Davis, and a BVSc from the University of Queensland, Dr. Er’s career blends scientific excellence with public service. 🎓🌍 His pioneering research on influenza A(H1N1)pdm09 virus infection in pigs has had lasting impacts on veterinary public health. 🦠📖 A committed scholar with 14 peer-reviewed publications, Dr. Er exemplifies the qualities honored by the Pioneer Researcher Award. 🏆✨

Publication  Profile

Orcid

Education 

Dr. Jwee Chiek Er holds a rich academic background dedicated to veterinary science and epidemiology. 🎓🐾 He earned his Ph.D. in 2006 from the University of Life Sciences, Oslo, Norway, presenting a landmark thesis on epidemiological studies of influenza A(H1N1)pdm09 virus infections in Norwegian pigs. 🇳🇴📚 He pursued his Master’s in Preventive Veterinary Medicine (MPVM) at the prestigious University of California, Davis, USA, graduating in 2000 with a focus on Veterinary Epidemiology. 🇺🇸📊 Dr. Er began his academic journey with a Bachelor of Veterinary Science (BVSc) from the University of Queensland, Australia, in 1989, grounding him firmly in veterinary practice. 🇦🇺🩺 His education reflects a lifelong commitment to enhancing animal health and advancing veterinary epidemiology through global learning experiences, interdisciplinary knowledge, and applied research, making him a fitting nominee for the Pioneer Researcher Award. 🏅🌟

Experience 

Dr. Jwee Chiek Er’s professional journey reflects outstanding dedication across diverse fields. 🌟 From 2007 onwards, he has been a full-time researcher at the Norwegian Veterinary Institute, specializing in epidemiology and bioinformatics. 🐷📊 In 2020, he also took on part-time service as a church servant at Uranienborg Menighet, den norsk luthersk kirke. ⛪ Before his research career, Dr. Er served in Singapore’s civil service (1991–2006), ensuring veterinary inspection and public health in pig and poultry slaughterhouses. 🐔🔍 He started his career in national service, where he rose to the rank of Captain in the Singapore Armed Forces as a logistics officer (1989–1991). 🎖️🚛 These extensive experiences demonstrate his leadership, scientific expertise, and commitment to public welfare. His professional background embodies the spirit of perseverance and innovation celebrated by the Pioneer Researcher Award. 🏅📈

Awards and Honors 

Dr. Jwee Chiek Er’s career is a testament to persistent excellence and leadership. 🌟 Although specific award listings were not detailed, his achievements themselves reflect high recognition in the veterinary science community. 🐾📈 His Ph.D. thesis and impactful peer-reviewed publications have significantly advanced knowledge of influenza epidemiology in pig populations, demonstrating award-worthy innovation. 🦠🔬 His pioneering surveillance work on influenza A(H1N1)pdm09 infections in Norway greatly contributed to national animal health strategies. 🇳🇴🐖 Furthermore, Dr. Er’s role in public veterinary service in Singapore and his distinguished service in the Singapore Armed Forces earned him respect and authority early in his career. 🎖️🌏 Nomination for the Pioneer Researcher Award is a fitting tribute to his lifelong dedication to animal health, epidemiological innovation, and scientific leadership. 🏅📚 His work bridges practice and research, influencing veterinary policies across nations. 🌐✨

Research Focus 

Dr. Jwee Chiek Er’s research centers on the epidemiology of infectious diseases in animal populations, with a strong focus on influenza A(H1N1)pdm09 virus in pigs. 🐖🦠 His studies analyze infection patterns, serosurveillance, and economic impacts on animal health, providing essential insights for disease control and public health policy. 📊🛡️ Using bioinformatics and mathematical modeling, such as discrete-time Markov Chain modeling, he projects disease prevalence and evaluates herd-level interventions. 📈🖥️ His research also explores serological cross-reactivity between influenza strains, crucial for improving diagnostic and surveillance systems. 🧬🔍 Through longitudinal studies at boar testing stations and comprehensive serological surveys, Dr. Er has significantly advanced understanding of viral behavior in livestock. 📑📈 His interdisciplinary approach integrating epidemiology, economics, and computational tools highlights him as a pioneer in veterinary research. 🏆🔬 His work supports healthier livestock systems and contributes to global food security. 🌍🍖

Publications Top Notes

  • 📄 “Adverse Effects of Influenza A(H1N1)Pdm09 Virus Infection on Growth Performance of Norwegian Pigs – a Longitudinal Study at a Boar Testing Station” (BMC Vet Res, 2014)

  • 📄 “Occurrence and Spread of Influenza A(H1N1)Pdm09 Virus Infection in Norwegian Pig Herds Based on Active Serosurveillance from 2010 to 2014” (Epidemiol Infect, 2016)

  • 📄 “Production Impact of Influenza A(H1N1)Pdm09 Virus Infection on Fattening Pigs in Norway” (J Anim Sci, 2016)

  • 📄 “Longitudinal Projection of Herd Prevalence of Influenza A(H1N1)Pdm09 Virus Infection in the Norwegian Pig Population by Discrete-Time Markov Chain Modelling” (Infectious Disease Reports, 2021)

  • 📄 “Antibodies of Influenza A(H1N1)Pdm09 Virus in Pigs’ Sera Cross-React with Other Influenza A Virus Subtypes: A Retrospective Epidemiological Interpretation of Norway’s Serosurveillance Data from 2009–2017” (Epidemiology and Infection, 2020)

  • 📄 “A Survey of Skin Neoplasms in Dogs from the Brisbane Region” (Aust Vet J, 1989)

Binhui Zhou | Biology and Life Sciences | Best Researcher Award

Published on by Research Hypothesis

Binhui Zhou | Biology and Life Sciences | Best Researcher Award

Assoc. Prof. Dr Binhui Zhou, Institute of Psychiatry and Neuroscience, China

Assoc. Prof. Dr. Binhui Zhou is a leading researcher in molecular biology and neuroscience, renowned for his work in protein palmitoylation and its implications in cancer and immune disorders 🔬🧠. He earned his Ph.D. in Crop Genetics and Breeding from Hainan University and currently serves as an Associate Professor at the Institute of Neuropsychiatry and Neuroscience, Xinxiang Medical University 🎓🏥. With over a decade of research, Dr. Zhou has pioneered studies funded by the National Natural Science Foundation of China and the Henan Provincial Foreign Expert Project 🇨🇳🌟. His groundbreaking publications in top-tier journals have significantly advanced our understanding of cellular signaling in diseases such as hepatocellular carcinoma and atherosclerosis 🧬🩸. A highly respected peer reviewer for prestigious journals, he continues to shape the scientific community through innovation and collaboration 🤝📚. Dr. Zhou exemplifies excellence in research and stands as a deserving candidate for the Best Researcher Award 🏆✨.

Publication Profile

Orcid

Education

Dr. Binhui Zhou’s educational journey reflects his strong commitment to bioscience and innovation 📘🧪. He began his academic career with a Bachelor’s degree in Bioengineering from Ningbo Institute of Technology, Zhejiang University (2005–2009) 🎓🔍. His passion for molecular and developmental biology led him to complete a Master’s degree in Developmental Biology at Hainan University (2010–2013), where he gained key insights into cell and tissue growth processes 🌱🧫. He pursued his Ph.D. at the same university in Crop Genetics and Breeding (2013–2017), where his research laid the foundation for his later studies on genetic regulation and disease pathways 🌾🧬. Throughout his education, Dr. Zhou displayed academic excellence, research depth, and a clear focus on translating fundamental biology into clinical relevance. His multidisciplinary academic background supports his current role as a prominent scientist exploring intersections of genetics, immunology, and neuroscience 🔍📖🧠.

Experience

Dr. Zhou began his academic career in 2017 as a Lecturer at the Institute of Neuropsychiatry and Neuroscience, Xinxiang Medical University 🏫🧠. Over seven years, he demonstrated outstanding research and teaching capabilities, contributing significantly to the fields of molecular biology and neuroimmunology 📚🔬. In 2024, he was promoted to Associate Professor in recognition of his impactful work on palmitoylation mechanisms and their clinical relevance in hepatocellular carcinoma and immune regulation 🧬🩺. His leadership in major research projects, such as NSFC Youth Program and Henan Foreign Expert Project, highlights his ability to lead innovative studies with real-world implications 🌍📊. In parallel, Dr. Zhou has served as a mentor to young scientists, shaping the next generation of researchers 👨‍🏫🌱. His dedication to cross-disciplinary collaboration and translational science continues to position him at the forefront of biomedical research.

Awards and Honors

Assoc. Prof. Dr. Binhui Zhou has received national recognition for his exceptional contributions to biomedical science 🧬🌟. As a Principal Investigator, he secured prestigious research grants, including the NSFC Youth Program and the Henan Provincial Foreign Expert Project, reflecting his leadership and innovation in high-impact studies 💡🧠. His work has been published in top-tier journals such as Cell Molecular Immunology, Theranostics, and Journal of Advanced Research, each with high impact factors and broad influence in global science communities 📈🌐. As an expert reviewer for journals like Communications Biology and Cell Communication and Signaling, he has helped uphold the integrity and quality of scientific publishing 📘🧪. Moreover, Dr. Zhou was appointed as a reviewer for the NSFC Youth Program, a mark of his standing in China’s scientific elite 🇨🇳📜. These accolades affirm his merit for the Best Researcher Award 🏅👏.

Research Focus

Dr. Zhou’s research primarily explores protein palmitoylation, a lipid modification process critical in regulating cellular signaling pathways in diseases such as cancer, atherosclerosis, and immune dysfunctions 🧪🧠. He focuses on zDHHC family palmitoyltransferases, particularly zDHHC1, zDHHC2, and zDHHC6, and their roles in modulating protein function in hepatocellular carcinoma and inflammatory responses 🔬🧬. His investigations have revealed mechanisms by which these enzymes control immune cell behavior and cancer cell proliferation, contributing to therapeutic target discovery 💊🔍. Notably, his studies on Foxp3 palmitoylation have uncovered novel immune regulatory pathways. Dr. Zhou also examines the PI3K-Akt-mTOR axis in relation to atherosclerosis, offering insights into cardiovascular disease treatment 🫀📊. His interdisciplinary approach bridges molecular biology, immunology, and neuroscience, pushing the boundaries of biomedical knowledge and guiding new treatment strategies across multiple health conditions 🤝🌍. His research stands at the forefront of cellular signaling and translational medicine 🚀🧫.

Publication Top Notes

Distinct palmitoylation of Foxp3 regulates the function of regulatory T cells via palmitoyltransferases

Protein palmitoylation in cancer: molecular functions and therapeutic potential

The palmitoylation of AEG-1 dynamically modulates the progression of hepatocellular carcinoma

A Murine Point Mutation of Sgpl1 Skin Is Enriched With Vγ6 IL17-Producing Cell and Revealed With Hyperpigmentation After Imiquimod Treatment

Excessive immunosuppression by regulatory T cells antagonizes T cell response to schistosome infection in PD-1-deficient mice

sgRNA Knock-in Mouse Provides an Alternative Approach for In Vivo Genetic Modification

Buddhi Fernando | Biology and Life Sciences | Best Researcher Award

Published on by Research Hypothesis

Buddhi Fernando | Biology and Life Sciences | Best Researcher Award

Dr Buddhi Fernando, Department of MLS, Faculty of Allied Health Sciences, University of Ruhuna, Galle, Sri Lanka

Dr. Buddhi Fernando is a dedicated academic and clinical biochemist from Sri Lanka 🇱🇰, currently serving as a Lecturer at the Department of Medical Laboratory Science, Faculty of Allied Health Sciences, University of Ruhuna. With a Ph.D. in Clinical Biochemistry from the University of Peradeniya 🎓, Dr. Fernando has pioneered studies on Chronic Kidney Disease of uncertain etiology (CKDu), identifying biomarkers for diagnosis, staging, and risk prediction 🧬🩺. With experience in teaching Clinical Biochemistry, Andrology, Microbiology, and more, she has inspired many students while conducting impactful research. Her award-winning research presentations and global exposure, including a scholarship to Japan 🌏, reflect her academic excellence. Dr. Fernando has co-authored numerous high-impact publications in reputed journals and remains passionate about translational science that directly benefits vulnerable communities. Her persistent pursuit of knowledge, interdisciplinary collaborations, and commitment to public health place her among Sri Lanka’s most promising researchers 🌟📚🔬.

Publication Profile

Google Scholar 

Education

Dr. Buddhi Fernando completed her Ph.D. in Clinical Biochemistry 🧪 at the Faculty of Medicine, University of Peradeniya, Sri Lanka, in 2020. Her dissertation focused on identifying a biomarker profile for CKDu and evaluating its utility in early diagnosis, staging, and risk stratification 🧬📊. She earned her B.Sc. in Medical Laboratory Science with a Second-Class Upper Division in 2014 from the Faculty of Allied Health Sciences, University of Peradeniya 🏥🔍. Her undergraduate research explored the impact of Diabetes Mellitus on heart function in ICR mice 🐭❤️. Earlier, she completed the G.C.E. Advanced Level Examination (2008) and G.C.E. Ordinary Level Examination (2002) with commendable results 🎓📘. Dr. Fernando’s academic training merges rigorous scientific methodology with a strong focus on public health relevance, especially in addressing rural disease burdens. Her scholarly foundation has been crucial in supporting her innovative research into CKDu, a condition affecting thousands in Sri Lanka 🩺🌱.

Experience

Dr. Buddhi Fernando has over six years of academic and teaching experience 📚. From November 2019 to date, she has served as a Lecturer (Probationary and then permanent) at the Department of Medical Laboratory Science, University of Ruhuna 🏫. Her teaching responsibilities span Clinical Biochemistry, Microbiology, Andrology, Physiology, and Parasitology 🧫🧠. She has also taken on leadership roles as Batch Coordinator and Unit Coordinator. Previously, she was a Demonstrator at the University of Peradeniya (2018–2019) and a Lecturer at IVA Para Medical Campus, Kandy (2018) 🧪. She is registered with the Sri Lanka Medical Council (Reg. No. 2478) 🧾. Her hands-on academic guidance and innovative methodologies help bridge theoretical learning with practical healthcare applications. Dr. Fernando’s commitment to education and mentorship has left a positive impact on future generations of medical laboratory professionals.

Awards and Honors

Dr. Buddhi Fernando’s excellence in research and academia has earned her several prestigious accolades 🌟. In 2012, she was awarded a scholarship for the Global Health Student Exchange Program at Niigata University, Japan, recognizing her early promise in global public health 🌍🇯🇵. In 2017, she won First Place for the Best Oral Presentation at the Research Sessions of the Kandy Society of Medicine 🥇🎤, showcasing her talent in communicating scientific breakthroughs effectively. Her outstanding scholarly output is reflected in numerous publications across high-impact journals such as PLoS ONE, Kidney International Reports, and Environmental Geochemistry and Health 📑📈. As a unit coordinator and mentor, her academic leadership has also been instrumental in enhancing research culture among peers and students 🧑‍🎓🔬. These honors exemplify her capability to contribute significantly to science, education, and community health — making her a strong contender for the Best Researcher Award 🏅📚🧪.

Research Focus

Dr. Buddhi Fernando’s research primarily centers on Chronic Kidney Disease of uncertain etiology (CKDu)—a pressing health crisis in Sri Lanka’s rural communities 🏞️🩺. Her Ph.D. work focused on identifying biomarker templates for CKDu and evaluating their utility for early detection, population screening, diagnosis, staging, and predicting complications 🧬💉. Her multidisciplinary approach integrates biochemical profiling, environmental toxicology, and molecular diagnostics to uncover the complex pathophysiology of CKDu. Beyond CKDu, she also explores diabetes-related cardiac effects and trace element imbalances ⚖️❤️. Dr. Fernando’s work has high translational value, aiming to bridge the gap between laboratory science and community health solutions 🧪🤝. Her collaborations with nephrologists, toxicologists, and global health experts reflect her broad academic network and research adaptability 🌐. Her contributions are vital to designing affordable, effective diagnostics for low-resource settings — making her research both locally relevant and globally significant 🌎📊🧠.

Publication Top Notes

Serum and urine fluoride levels in populations of high environmental fluoride exposure with endemic CKDu: a case–control study from Sri Lanka